Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia

Blood

Volumn 103, Issue 1, 2004, Pages 363-365

  Tournilhac, Olivier ^b   Cazin, Bruno ^b   Leprètre, Stéphane ^b   Diviné, Marine ^b   Maloum, Karim ^b   Delmer, Alain ^b   Grosbois, Bernard ^b   Feugier, Pierre ^b   Maloisel, Frederic ^b   Villard, Florence ^b   Villemagne, Bruno ^b   Bastit, Dominique ^b   Belhadj, Karim ^b   Azar, Nabi ^b   Michallet, Mauricette ^b   Manhès, Geraud ^b   Travade, Philippe ^a  

^a HÔTEL DIEU   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; FLUDARABINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; B CELL LEUKEMIA; CANCER COMBINATION CHEMOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; HUMAN; LEUKEMIA REMISSION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STEADY STATE; STEM CELL MOBILIZATION; THROMBOCYTE COUNT; TREATMENT OUTCOME;

EID: 9144222685     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-05-1449     Document Type: Article

References (22)

1. Dighiero G, Maloum K, Desablens B, et al. Chlorambucil in indolent chronic lymphocytic leukemia: French Cooperative Group on Chronic Lymphocytic Leukemia. N Engl J Med. 1998;338:1506-1514.
2. Provan D, Bartlett-Pandite L, Zwicky C, et al. Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood. 1996;88:2228-2235.
3. Robertson LE, Huh YO, Butler JJ, et al. Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis. Blood. 1992;80:29-36.
4. Rabinowe SN, Soiffier RJ, Gribben J, et al. Autologous and allogenic bone marrow transplantation for poor prognosis patients with B-cell chronic leukemia. Blood. 1993;82;1366-1376.
5. Khouri IF, Keating MJ, Vriesendorp HM, et al. Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results. J Clin Oncol. 1994;12:748-758.
6. Michallet M, Archimbaud E, Bandini G, et al. HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia: European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry. Ann Intern Med. 1996;124:311-315.
7. Leporrier M, Chevret S, Cazin B, et al. Randomized comparison of fludarabine, CAP, and CHOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. Blood. 2001;98:2319-2325.
8. Rai KR, Peterson BL, Appelbaum FR, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med. 2000;343:1750-1757.
9. Boogaerts MA, Van Hoof A, Catovsky D, et al. Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia. J Clin Oncol. 2001;19:4252-4258.
10. O'Brien SM, Kantarjian HM, Cortes J, et al. Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia. J Clin Oncol. 2001;19:1414-1420.
11. Cazin B, Maloum K, Divine M, et al. Oral fludarabine and cyclophosphamide in previously untreated CLL: preliminary data on 75 patients [abstract]. Blood. 2002;100:773.
12. Keating M, Manshouri T, O'Brien S, et al. A high proportion of molecular remission can be obtained with fludarabine, cyclophosphamide, rituximab combination (FCR) in chronic lymphocytic leukemia (CLL) [abstract]. Blood. 2002;100:205.
13. Michallet M, Thiebaut A, Dreger P, et al. Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemia Working Party (CLWP). Br J Haematol. 2000;108:595-601.
14. + priming with intermediate dose Ara-C (ID ARA-C) in chronic lymphocytic leukemia (CLL) patients treated with sequential fludarabine (FAMP) and campath-1H [abstract]. Blood. 2002;100:830.
15. Dreger P, Montserrat E. Autologous and allogenic stem cell transplantation for chronic lymphocytic leukemia. Leukemia. 2002;16:985-992.
16. Itala M, Pelliniemi TT, Rajamaki A, Remes K. Autologous blood cell transplantation in B-CLL: response to chemotherapy prior to mobilization predicts the stem cell yield. Bone Marrow Transplant. 1997;19:647-651.
17. Ketterer N, Salles G, Moullet I, et al. Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br J Haematol. 1998;103:235-242.
18. Laszlo D, Galieni P, Raspadori D, et al. Fludarabine-containing regimens may adversely affect peripheral blood stem cell collection in low-grade non Hodgkin lymphoma patients. Leuk Lymphoma. 2000;37:157-161.
19. Visani G, Lemoli RM, Tosi P, et al. Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients. Br J Haematol. 1999;105:775-779.
20. Dreger P, Viehmann K, von Neuhoff N, et al. A prospective study of positive/negative ex vivo B-cell depletion in patients with chronic lymphocytic leukemia. Exp Hematol. 2000;28:1187-1196.
21. Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996;87:4990-4997.
22. Burger JA, Kipps TJ. Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells. Leuk Lymphoma 2002;43:461-466.